Inovio Pharmaceuticals Statistics
Total Valuation
INO has a market cap or net worth of $86.63 million. The enterprise value is $49.74 million.
Important Dates
The last earnings date was Tuesday, August 12, 2025, after market close.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
INO has 50.96 million shares outstanding. The number of shares has increased by 41.82% in one year.
| Current Share Class | 50.96M |
| Shares Outstanding | 50.96M |
| Shares Change (YoY) | +41.82% |
| Shares Change (QoQ) | +0.56% |
| Owned by Insiders (%) | 0.95% |
| Owned by Institutions (%) | 15.84% |
| Float | 47.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 475.12 |
| Forward PS | n/a |
| PB Ratio | 3.17 |
| P/TBV Ratio | 3.04 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 272.79 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.37.
| Current Ratio | 1.66 |
| Quick Ratio | 1.53 |
| Debt / Equity | 0.37 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -140.12% and return on invested capital (ROIC) is -80.46%.
| Return on Equity (ROE) | -140.12% |
| Return on Assets (ROA) | -59.30% |
| Return on Invested Capital (ROIC) | -80.46% |
| Return on Capital Employed (ROCE) | -262.37% |
| Revenue Per Employee | $1,361 |
| Profits Per Employee | -$654,935 |
| Employee Count | 134 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -79.57% in the last 52 weeks. The beta is 1.39, so INO's price volatility has been higher than the market average.
| Beta (5Y) | 1.39 |
| 52-Week Price Change | -79.57% |
| 50-Day Moving Average | 1.71 |
| 200-Day Moving Average | 2.36 |
| Relative Strength Index (RSI) | 61.77 |
| Average Volume (20 Days) | 1,397,873 |
Short Selling Information
The latest short interest is 5.10 million, so 10.00% of the outstanding shares have been sold short.
| Short Interest | 5.10M |
| Short Previous Month | 5.99M |
| Short % of Shares Out | 10.00% |
| Short % of Float | 10.76% |
| Short Ratio (days to cover) | 1.67 |
Income Statement
In the last 12 months, INO had revenue of $182,337 and -$87.76 million in losses. Loss per share was -$2.60.
| Revenue | 182,337 |
| Gross Profit | -75.44M |
| Operating Income | -95.85M |
| Pretax Income | -121.64M |
| Net Income | -87.76M |
| EBITDA | -94.29M |
| EBIT | -95.85M |
| Loss Per Share | -$2.60 |
Full Income StatementBalance Sheet
The company has $47.55 million in cash and $10.66 million in debt, giving a net cash position of $36.89 million or $0.72 per share.
| Cash & Cash Equivalents | 47.55M |
| Total Debt | 10.66M |
| Net Cash | 36.89M |
| Net Cash Per Share | $0.72 |
| Equity (Book Value) | 28.53M |
| Book Value Per Share | 0.54 |
| Working Capital | 20.99M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$94.79 million and capital expenditures -$90,303, giving a free cash flow of -$94.88 million.
| Operating Cash Flow | -94.79M |
| Capital Expenditures | -90,303 |
| Free Cash Flow | -94.88M |
| FCF Per Share | -$1.86 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -52,568.64% |
| Pretax Margin | -48,131.35% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
INO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -41.82% |
| Shareholder Yield | n/a |
| Earnings Yield | -101.30% |
| FCF Yield | -109.53% |
Dividend DetailsAnalyst Forecast
The average price target for INO is $8.80, which is 417.65% higher than the current price. The consensus rating is "Buy".
| Price Target | $8.80 |
| Price Target Difference | 417.65% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 309.40% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 25, 2024. It was a reverse split with a ratio of 1:12.
| Last Split Date | Jan 25, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |